EGFR inhibitors erlotinib and lapatinib ameliorate epidermal blistering in pemphigus vulgaris in a non-linear, V-shaped relationship

Neural nitric oxide synthase participates in pemphigus vulgaris acantholysis through upregulation of Rous sarcoma, mammalian target of rapamycin and focal adhesion kinase

(2013) Agustín España et al.   EXPERIMENTAL DERMATOLOGY

Epidermal EGFR Controls Cutaneous Host Defense and Prevents Inflammation

(2013) B. M. Lichtenberger et al.   Science Translational Medicine

Inhibition of FAK prevents blister formation in the neonatal mouse model of pemphigus vulgaris

(2012) María P. Gil et al.   EXPERIMENTAL DERMATOLOGY

An Adult Passive Transfer Mouse Model to Study Desmoglein 3 Signaling in Pemphigus Vulgaris

(2011) Katja Schulze et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Autocrine VEGF Signaling Synergizes with EGFR in Tumor Cells to Promote Epithelial Cancer Development

(2010) Beate M. Lichtenberger et al.   CELL

p38 MAPK Activation Is Downstream of the Loss of Intercellular Adhesion in Pemphigus Vulgaris

(2010) Xuming Mao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

From Cell Signaling to Novel Therapeutic Concepts: International Pemphigus Meeting on Advances in Pemphigus Research and Therapy

(2010) Spiro Getsios et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Desmoglein 3, via an Interaction with E-cadherin, Is Associated with Activation of Src

(2010) Siu Man Tsang et al.   PLoS One

Pemphigus Vulgaris IgG Cause Loss of Desmoglein-Mediated Adhesion and Keratinocyte Dissociation Independent of Epidermal Growth Factor Receptor

(2009) Wolfgang-Moritz Heupel et al.   AMERICAN JOURNAL OF PATHOLOGY

An imbalance in Akt/mTOR is involved in the apoptotic and acantholytic processes in a mouse model of pemphigus vulgaris

(2009) Maider Pretel et al.   EXPERIMENTAL DERMATOLOGY

A Case of Bullous Dermatitis Induced by Erlotinib

(2009) A. Oteri et al.   ONCOLOGIST

Lapatinib: A dual inhibitor of human epidermal growth factor receptor tyrosine kinases

(2008) P MEDINA et al.   CLINICAL THERAPEUTICS

Outside-in Signaling through Integrins and Cadherins: A Central Mechanism to Control Epidermal Growth and Differentiation?

(2008) Eliane J. Müller et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY